Bright Minds Biosciences (DRUG)'s 30-day implied volatility (IV30) was 80.5% at the close on November 6, 2026, down from 88.2% the day before, against a 52-week range of 49.8% to 88.2%. Its 20-day historical volatility was 109.2%.
Data as of November 6, 2026.